Latest stories on TLSA
Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto
GlobeNewswire50 · neutralproduct/pr
Tiziana Life Sciences doses last patient in foralumab trial
The Fly58 · neutralproduct/pr
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease
Business Insider58 · neutralproduct/pr
Tiziana Life submits request to U.S. FDA for ODD for intranasal foralumab
The Fly59 · neutralgeneral
Tiziana Life announces first 3 participants received first dose in ALS BANYAN
The Fly59 · neutralproduct/pr
Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab
GlobeNewswire63 · neutralproduct/pr
Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab
Business Insider59 · neutralproduct/pr
Tiziana Life Sciences announces last patient completed Phase 2a INFORM-MS trial
The Fly63 · neutralproduct/pr
Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab
GlobeNewswire59 · neutralproduct/pr
Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab
Business Insider63 · neutralproduct/pr
Tiziana’s RRMS collaboration plan adds a new clinical angle for intranasal foralumab
September 17, 2026
MarketChameleon63 · neutralproduct/pr
Tiziana Life Sciences stock jumps on MS trial partnership
Investing.com Markets63 · neutralproduct/pr
Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial
TipRanks63 · neutralproduct/pr
Tiziana Life Sciences signs MOU with KAIMRC in Saudi Arabia
The Fly63 · neutralproduct/pr
Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center
Business Insider63 · neutralproduct/pr
Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center
GlobeNewswire59 · neutralgeneral
BTIG initiates Tiziana Life Sciences stock with buy on MS drug
Investing.com Analyst Ratings61 · neutralanalyst
Tiziana Life Sciences initiated with a Buy at BTIG
The Fly61 · neutralanalyst
Tiziana Life Sciences Showcases Phase 2a BANYAN Trial of Intranasal Foralumab for ALS at ALS Nexus 2026
TipRanks63 · neutralproduct/pr
Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026
Business Insider59 · neutralproduct/pr
Tiziana Life Sciences Ceo Ivor Elrifi Purchases 321423 Shares
The Fly56 · neutralgeneral
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
StockTitan56 · neutralgeneral
Tiziana Life Sciences CEO Boosts Stake as Lead MS Therapy Progresses
TipRanks63 · neutralgeneral